PHIO Q3 2025 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena

PHIOPhio Pharmaceuticals Corp.

$13M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$2,000

Operating Income

-$3M

Net Income

-$2M

EPS (Diluted)

$-0.44

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$113,000

Balance Sheet

Total Assets

$12M

Total Liabilities

$2M

Stockholders' Equity

$10M

Cash & Equivalents

$11M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$2,000	-$644,000	+99.7%
Operating Income	-$3M	-$2M	-57.5%
Net Income	-$2M	-$2M	-57.0%